BioPathogenix
BioPathogenix is a U.S. biotechnology firm (founded 2020, Nicholasville, KY) that sells specimen collection supplies, DNA/RNA extraction reagents, and PCR lab consumables, and runs the 'qPCR & Pathogen Detection Circle' LinkedIn community for global molecular diagnostic researchers.
- Company typePrivate
- Founded2020
- HeadquartersNicholasville, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What BioPathogenix does
BioPathogenix is a privately held U.S. biotechnology company founded in 2020 and headquartered in Nicholasville, Kentucky. Per its own materials, it supplies specimen collection products, DNA/RNA extraction reagents, and PCR lab consumables to the molecular diagnostics and pathogen detection market. Its stated core technology is quantitative Polymerase Chain Reaction (qPCR), and the firm describes itself as a U.S.-based leader in qPCR for molecular diagnostic practices and pathogen detection.
Beyond its reagent and consumables catalog, BioPathogenix operates a community-led go-to-market motion anchored on the 'qPCR & Pathogen Detection Circle', a LinkedIn-based community initiative launched on 2025-10-22 and led by Yue Yu. The community targets global researchers and molecular diagnostic professionals with knowledge sharing, troubleshooting, and collaboration around qPCR practices, positioning the company as a horizontal provider to the practitioner community rather than through a disclosed distributor or e-commerce channel. The firm sits in a horizontal market segment serving an undefined customer base; no specific customer logos, contract structures, or distributor partnerships are disclosed in the input data.
The business model is incompletely characterized. Pricing is not publicly disclosed, revenue figures are absent, no funding rounds are on record, and headcount is stated only as a band of 11–50 employees. The company's stated office activity includes local community support (food drives, food insecurity initiatives) at its Nicholasville headquarters, and operating geographies are reported only at Kentucky/state level with an international reach claim tied to the LinkedIn community rather than disclosed sales infrastructure.
BioPathogenix firmographics
Firmographics- Name
- BioPathogenix
- Website
- https://biopathogenix.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- BioPathogenix is a U.S. biotechnology firm (founded 2020, Nicholasville, KY) that sells specimen collection supplies, DNA/RNA extraction reagents, and PCR lab consumables, and runs the 'qPCR & Pathogen Detection Circle' LinkedIn community for global molecular diagnostic researchers.
- Ownership category
- akta.pro rank
BioPathogenix industry classification
Industry- Product category
- Molecular Diagnostics Reagents and PCR Consumables
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
- akta.pro primary industry
- Molecular Diagnostics (PCR/qPCR, NGS-based assays) (HLAAALAA)
- akta.pro secondary industry
- Sample / Biorepository & Biobank Informatics (Chain-of-Custody) (HLAGAJAH)
Keywords
Where BioPathogenix is headquartered
LocationHeadquarters
- HQ city
- Nicholasville
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
BioPathogenix business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales
Go-to-market motion1 record
Marketing channels1 record
BioPathogenix product offering
Product offeringCore offering
BioPathogenix provides specimen collection supplies, DNA/RNA extraction reagents, and PCR lab consumables for molecular diagnostics and pathogen detection laboratories. The company applies qPCR (quantitative Polymerase Chain Reaction) technology to support researchers and diagnostic professionals with the consumables needed to run pathogen detection workflows. It complements these physical product offerings with a community-led engagement platform on LinkedIn that connects global researchers in the qPCR field.
Product overview
BioPathogenix is a biotechnology company specializing in qPCR (quantitative Polymerase Chain Reaction) technology for molecular diagnostics and pathogen detection. The company operates a LinkedIn community platform called the 'qPCR & Pathogen Detection Circle' to unite global researchers and elevate PCR practices through collaboration and knowledge sharing.
Differentiator
Problem solved
Functional benefit
Products and services
- Specimen collection supplies
Companies that use BioPathogenix
Customer profileSegments1 record
Ideal customer profiles1 record
BioPathogenix technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
BioPathogenix partnerships and signals
Strategic signalScale indicators1 record
Recent moves2 records
Expansion highlights3 records
BioPathogenix competitors and assessment
Company assessmentDirect peers
- Zymo Research: Zymo Research specializes in DNA/RNA extraction kits, sample collection devices, and qPCR reagents, with a comparable focus on pathogen detection and microbiome applications. It is a similarly sized specialist competing in BioPathogenix's exact niches.
- Qiagen: Qiagen is a direct peer with leading positions in DNA/RNA extraction kits (e.g., QIAamp) and PCR consumables, serving molecular diagnostics and research customers globally — the same upstream qPCR workflow BioPathogenix targets.
- LGC Biosearch Technologies: LGC Biosearch Technologies offers qPCR probes, primers, and master mixes for pathogen detection and genetic testing. It is a comparable specialty consumables supplier serving molecular diagnostic researchers globally.
- Promega Corporation: Promega provides DNA/RNA extraction reagents, PCR/qPCR master mixes, and specimen collection supplies to research and clinical labs. Its product categories directly mirror BioPathogenix's specimen-to-result consumables offering.
- New England Biolabs (NEB): NEB supplies PCR/qPCR reagents, polymerases, and molecular biology enzymes used in pathogen detection workflows. It competes head-on with BioPathogenix in research-grade PCR consumables and reagent kits.
- Bio-Rad Laboratories: Bio-Rad is a direct competitor offering PCR/qPCR instruments, reagents, extraction kits, and consumables across research and diagnostic markets. Its CFX qPCR systems and reagent portfolio overlap almost entirely with BioPathogenix's qPCR workflow focus.
- Integrated DNA Technologies (IDT): IDT supplies oligonucleotides, qPCR probe-based assays, and DNA/RNA reagents used in pathogen detection workflows. It is a comparable specialty supplier serving molecular diagnostic researchers.
Broad incumbents
- Roche Diagnostics: Roche Diagnostics, through its Molecular Diagnostics portfolio, sells PCR-based assays, extraction reagents, and automated workflows. It competes for the same clinical and research pathogen-detection budgets as BioPathogenix, but at far greater scale.
- Thermo Fisher Scientific: Thermo Fisher is a broad incumbent offering Applied Biosystems qPCR instruments and reagents, extraction kits, and specimen collection products. It is the dominant end-to-end supplier against which BioPathogenix must position its niche consumables offering.
- Agilent Technologies: Agilent provides qPCR instruments, molecular biology reagents, and related consumables serving research and applied markets. Its broad life sciences portfolio overlaps with BioPathogenix's consumables offering.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat2 records
Key risks1 record
Customer concentration
BioPathogenix social profiles
Digital presenceBioPathogenix financial estimates
Financial estimateRevenue estimate
Valuation estimate
BioPathogenix leadership team
Management profileNumber of profiles
Profiles1 record
BioPathogenix funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BioPathogenix M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BioPathogenix
What does BioPathogenix do?
BioPathogenix provides specimen collection supplies, DNA/RNA extraction reagents, and PCR lab consumables for molecular diagnostics and pathogen detection laboratories. The company applies qPCR (quantitative Polymerase Chain Reaction) technology to support researchers and diagnostic professionals with the consumables needed to run pathogen detection workflows. It complements these physical product offerings with a community-led engagement platform on LinkedIn that connects global researchers in the qPCR field.
Is BioPathogenix a public or private company?
BioPathogenix is a private company. It is classified as unknown and is currently operating.
When was BioPathogenix founded?
BioPathogenix was founded in 2020. It employs 11 to 50 people.
Where is BioPathogenix based?
BioPathogenix is headquartered in Nicholasville, United States, in the North America region.
Who are BioPathogenix's main competitors?
Direct peers on record are Zymo Research, Qiagen, LGC Biosearch Technologies, Promega Corporation, New England Biolabs (NEB), Bio-Rad Laboratories and Integrated DNA Technologies (IDT). Broad incumbents are Roche Diagnostics, Thermo Fisher Scientific and Agilent Technologies.
Does BioPathogenix have an API?
No public API is recorded for BioPathogenix.
What industry is BioPathogenix in?
BioPathogenix's product category is Molecular Diagnostics Reagents and PCR Consumables. Its primary akta.pro industry code is HLAAALAA, Molecular Diagnostics (PCR/qPCR, NGS-based assays), with a secondary code of HLAGAJAH, Sample / Biorepository & Biobank Informatics (Chain-of-Custody). Its NAICS code is 325413 and its SIC code is 2835.